Our website uses cookies to improve your on-site experience. By using the website, cookies are being used as described in our Policy Document
Warning: To log in you will need to enable cookies and reload the page (Policy Document)
My ePortfolio Register   

SIOG 2017 /
The promise of immunotherapy for elderly patients

9th - 11th Nov 2017

Please rate this video

Please complete at least one question.

  1. The information in this video was of interest to me Disagree Agree
  2. The information in this video is likely to improve my clinical practice or research Disagree Agree
  3. I would recommend this video to my colleagues Disagree Agree
Thanks for rating
There has been a problem, please refresh and try again.
Published: 15.11.17
Views: 556

Dr Alistair Greystoke - Newcastle University, Newcastle, UK

Dr Alistair Greystoke talks to ecancer at SIOG 2017 in Warsaw.

He discusses the benefits of immunotherapies, with a focus on older caner patients. 

Dr Greystoke highlights that there are not enough clinical trials with older patients taking part. 

He goes into deeper details about the response biomarkers for immunotherapies.

The future prospects of immuntherapies are good, and Dr Greystoke touches on some of the ways progress is being made.

This service has been kindly supported by an unrestricted grant from Janssen Oncology.

Previous conferences: highlights

Founding partners

European Cancer Organisation European Institute of Oncology

Founding Charities

Foundazione Umberto Veronesi Fondazione IEO Swiss Bridge

Published by

ecancer Global Foundation